Sequenom Posts 18 Percent Q3 Revenue Growth | GenomeWeb
NEW YORK (GenomeWeb News) – Sequenom said after the close of the market Thursday that its third-quarter revenues rose 18 percent, while its net loss jumped 89 percent on higher R&D costs and licensing payments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.